Bristol-Myers Squibb has signed another deal to build its capabilities in antibody-drug conjugates for cancer, paying $100 million upfront to take control of an Orum Therapeutics candidate with a ...

I Tested Starlink’s Low-Cost $80-Per-Month Plan: It's Not the Downgrade I Expected By Brian Westover A Free One-Click Fix for Slow Computers? I Put Microsoft's PC Manager App to the Test By Michael ...